Abstract |
Subclinical vitamin C deficiency is widespread in many populations, but its role in both Alzheimer's disease and normal aging is understudied. In the present study, we decreased brain vitamin C in the APPSWE/PSEN1deltaE9 mouse model of Alzheimer's disease by crossing APP/PSEN1(+) bigenic mice with SVCT2(+/-) heterozygous knockout mice, which have lower numbers of the sodium-dependent vitamin C transporter required for neuronal vitamin C transport. SVCT2(+/-) mice performed less well on the rotarod task at both 5 and 12 months of age compared to littermates. SVCT2(+/-) and APP/PSEN1(+) mice and the combination genotype SVCT2(+/-)APP/PSEN1(+) were also impaired on multiple tests of cognitive ability (olfactory memory task, Y-maze alternation, conditioned fear, Morris water maze). In younger mice, both low vitamin C (SVCT2(+/-)) and APP/PSEN1 mutations increased brain cortex oxidative stress ( malondialdehyde, protein carbonyls, F2-isoprostanes) and decreased total glutathione compared to wild-type controls. SVCT2(+/-) mice also had increased amounts of both soluble and insoluble Aβ1-42 and a higher Aβ1-42/1-40 ratio. By 14 months of age, oxidative stress levels were similar among groups, but there were more amyloid-β plaque deposits in both hippocampus and cortex of SVCT2(+/-)APP/PSEN1(+) mice compared to APP/PSEN1(+) mice with normal brain vitamin C. These data suggest that even moderate intracellular vitamin C deficiency plays an important role in accelerating amyloid pathogenesis, particularly during early stages of disease development, and that these effects are likely modulated by oxidative stress pathways.
|
Authors | Shilpy Dixit, Alexandra Bernardo, Jennifer Michelle Walker, John Andrew Kennard, Grace Youngeun Kim, Eric Sean Kessler, Fiona Edith Harrison |
Journal | ACS chemical neuroscience
(ACS Chem Neurosci)
Vol. 6
Issue 4
Pg. 570-81
(Apr 15 2015)
ISSN: 1948-7193 [Electronic] United States |
PMID | 25642732
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- APP protein, human
- Amyloid beta-Peptides
- Amyloid beta-Protein Precursor
- PSEN1 protein, human
- Peptide Fragments
- Presenilin-1
- Slc23a2 protein, mouse
- Sodium-Coupled Vitamin C Transporters
- amyloid beta-protein (1-40)
- amyloid beta-protein (1-42)
- Ascorbic Acid
|
Topics |
- Aging
(metabolism, pathology)
- Alzheimer Disease
(metabolism, pathology)
- Amyloid beta-Peptides
(metabolism)
- Amyloid beta-Protein Precursor
(genetics, metabolism)
- Animals
- Anxiety
(metabolism, pathology)
- Ascorbic Acid
(metabolism)
- Ascorbic Acid Deficiency
(metabolism, pathology, psychology)
- Brain
(metabolism, pathology)
- Cognition Disorders
(metabolism, pathology)
- Disease Models, Animal
- Female
- Learning
(physiology)
- Male
- Memory
(physiology)
- Mice, Transgenic
- Motor Activity
(physiology)
- Oxidative Stress
(physiology)
- Peptide Fragments
(metabolism)
- Presenilin-1
(genetics, metabolism)
- Sodium-Coupled Vitamin C Transporters
(genetics, metabolism)
|